Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2020-01-30 2020-01-17
Drug Identification Number 00342092 00342092
Brand name TEVA-CEPHALEXIN 250 TEVA-CEPHALEXIN 250
Common or Proper name CEPHALEXIN 250MG FOS CEPHALEXIN 250MG FOS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CEPHALEXIN CEPHALEXIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ML 100ML
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15 2020-01-15
Estimated end date 2020-02-29 2020-02-29
Actual end date 2020-01-29
Shortage status Resolved Actual shortage
Company comments
Health Canada comments